ENOVIS CORPORATION
(NYSE: ENOV)
Enovis Corp. operates as a medical technology growth company. It develops clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. The firm operates through the following segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative disease. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. The company was founded by Mitchell P. Rales and Steven M. Rales in 1995 and is headquartered in Wilmington, DE.
43.230
+1.960
(+4.75%)
Range
41.556 - 43.230
(4.03%)
Open
41.580
Previous Close
41.270
Bid Price
69.180
Bid Volume
8
Ask Price
69.200
Ask Volume
10
Volume
209,418
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis